CIK 0001689375 · Accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entrada Therapeutics, Inc.
Sign in to watch- Ticker
- TRDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 813983399
- Phone
- 857-305-1825
- Business address
- ONE DESIGN CENTER PLACE, SUITE 17-500, BOSTON, MA, 02210
- Former names
- CycloPorters, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,200,939
- in 8 filings
Net −$7,200,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-09 | MPM BIOVENTURES 2018, L.P. 10% owner | Sale | −28,837 | $7.13 | $206K | 3,885,115 |
| 2026-09-09 | MPM BioVentures 2014, L.P. 10% owner | Sale | −28,837 | $7.13 | $206K | 3,885,115 |
| 2026-09-08 | MPM BIOVENTURES 2018, L.P. 10% owner | Sale | −192,500 | $7.41 | $1.4M | 3,913,952 |
| 2026-09-08 | MPM BioVentures 2014, L.P. 10% owner | Sale | −192,500 | $7.41 | $1.4M | 3,913,952 |
| 2026-09-04 | MPM BIOVENTURES 2018, L.P. 10% owner | Sale | −38,500 | $7.11 | $274K | 4,106,452 |
| 2026-09-04 | MPM BioVentures 2014, L.P. 10% owner | Sale | −38,500 | $7.11 | $274K | 4,106,452 |
| 2026-09-03 | MPM BIOVENTURES 2018, L.P. 10% owner | Sale | −32,263 | $7.17 | $231K | 4,144,952 |
| 2026-09-03 | MPM BioVentures 2014, L.P. 10% owner | Sale | −32,263 | $7.17 | $231K | 4,144,952 |
| 2026-09-02 | Sethuraman Natarajan President, Research & Develop. | Shares withheld for taxes | −2,079 | $7.14 | $15K | 214,238 |
| 2026-09-02 | Dowden Nathan J President & COO | Shares withheld for taxes | −2,528 | $7.14 | $18K | 196,060 |
| 2026-09-02 | WENTWORTH KORY JAMES Chief Financial Officer | Shares withheld for taxes | −1,733 | $7.14 | $12K | 117,277 |
| 2026-09-02 | Doshi Dipal CEO | Shares withheld for taxes | −8,724 | $7.14 | $62K | 517,290 |
| 2026-09-02 | MPM BIOVENTURES 2018, L.P. 10% owner | Sale | −25,131 | $7.19 | $181K | 4,177,215 |
| 2026-09-02 | MPM BioVentures 2014, L.P. 10% owner | Sale | −25,131 | $7.19 | $181K | 4,177,215 |
| 2026-09-01 | MPM BIOVENTURES 2018, L.P. 10% owner | Sale | −29,088 | $7.06 | $205K | 4,202,346 |
| 2026-09-01 | MPM BioVentures 2014, L.P. 10% owner | Sale | −29,088 | $7.06 | $205K | 4,202,346 |
| 2026-08-31 | MPM BIOVENTURES 2018, L.P. 10% owner | Sale | −44,259 | $6.99 | $309K | 4,231,434 |
| 2026-08-31 | MPM BioVentures 2014, L.P. 10% owner | Sale | −44,259 | $6.99 | $309K | 4,231,434 |
| 2026-08-28 | MPM BIOVENTURES 2018, L.P. 10% owner | Sale | −3,733 | $7.01 | $26K | 4,275,693 |
| 2026-08-28 | MPM BioVentures 2014, L.P. 10% owner | Sale | −3,733 | $7.01 | $26K | 4,275,693 |
Page 1 of 12 · 230 trades